Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicity Lose

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Biological Chemistry|May 14, 2013
Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseasesJyotsna Batra, Tracy O'Mara, Radhika Patnala, et al.
Journal of the National Cancer Institute|October 30, 2008
Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1Felicity Lose, David L Duffy, Graham F Kay, et al.
Breast Cancer Research : BCR|June 10, 2006
Variation in the RAD51 gene and familial breast cancerFelicity Lose, Paul Lovelock, Georgia Chenevix-Trench, et al.
American Journal of Epidemiology|November 17, 2011
A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese populationJyotsna Batra, Felicity Lose, Suzanne Chambers, et al.
Lymphatic Research and Biology|March 13, 2012
Possible genetic predisposition to lymphedema after breast cancerBeth Newman, Felicity Lose, Mary-Anne Kedda, et al.
Plos One|September 13, 2012
Genetic association of the KLK4 locus with risk of prostate cancerFelicity Lose, Srilakshmi Srinivasan, Tracy O'Mara, et al.
Breast Cancer Research : BCR|August 19, 2007
BCoR-L1 variation and breast cancerFelicity Lose, Jeremy Arnold, David B Young, et al.
Biological Chemistry|April 17, 2012
The kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressivenessFelicity Lose, Mitchell G Lawrence, Srilakshmi Srinivasan, et al.
Gynecologic Oncology|December 9, 2017
ER and PR expression and survival after endometrial cancerDeborah Smith, Colin J R Stewart, Edward M Clarke, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 1, 2015
Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general populationKimberly E Alexander, Suzanne Chambers, Amanda B Spurdle, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Biological Chemistry|May 14, 2013
Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseasesJyotsna Batra, Tracy O'Mara, Radhika Patnala, et al.
Journal of the National Cancer Institute|October 30, 2008
Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1Felicity Lose, David L Duffy, Graham F Kay, et al.
Breast Cancer Research : BCR|June 10, 2006
Variation in the RAD51 gene and familial breast cancerFelicity Lose, Paul Lovelock, Georgia Chenevix-Trench, et al.
American Journal of Epidemiology|November 17, 2011
A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese populationJyotsna Batra, Felicity Lose, Suzanne Chambers, et al.
Lymphatic Research and Biology|March 13, 2012
Possible genetic predisposition to lymphedema after breast cancerBeth Newman, Felicity Lose, Mary-Anne Kedda, et al.
Plos One|September 13, 2012
Genetic association of the KLK4 locus with risk of prostate cancerFelicity Lose, Srilakshmi Srinivasan, Tracy O'Mara, et al.
Breast Cancer Research : BCR|August 19, 2007
BCoR-L1 variation and breast cancerFelicity Lose, Jeremy Arnold, David B Young, et al.
Biological Chemistry|April 17, 2012
The kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressivenessFelicity Lose, Mitchell G Lawrence, Srilakshmi Srinivasan, et al.
Gynecologic Oncology|December 9, 2017
ER and PR expression and survival after endometrial cancerDeborah Smith, Colin J R Stewart, Edward M Clarke, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 1, 2015
Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general populationKimberly E Alexander, Suzanne Chambers, Amanda B Spurdle, et al.
Pageof 3